Method and device to monitor patients with kidney disease

Patent metadata

Field	Value
Publication number	US-9848778-B2
Application number	US-201313844257-A
Country	US
Kind code	B2
Filing date	Mar 15, 2013
Priority date	Apr 29, 2011
Publication date	Dec 26, 2017
Grant date	Dec 26, 2017

Abstract

A medical monitoring device for monitoring electrical signals from the body of a subject is described. The medical monitoring device monitors electrical signals originating from a cardiac cycle of the subject and associates each cardiac cycle with a time index. The medical monitoring device applies a forward computational procedure to generate a risk score indicative of hyperkalemia, hypokalemia or arrhythmia of the subject. The medical monitoring device can adjust the forward computational procedure based upon clinical data obtained from the subject.

First claim

We claim:

1. A medical system comprising:
a medical device including at least one of an electromyogram sensor and/or at least one of an electrocardiogram sensor for detecting a change in muscle or nerve activity of a subject and for producing at least one output electrical signal based on the change in muscle or nerve activity as detected by at least one received electrical signal, the output electrical signal being indicative of a serum potassium concentration of the subject;
a processor for applying a forward computational procedure to the at least one received electrical signal to generate a risk score for hyperkalemia, hypokalemia or arrhythmia;
a communication device indicating a condition of hyperkalemia, hypokalemia or arrhythmia of the subject based on the risk score;
wherein the electrocardiogram sensor includes one or more electrocardiogram electrodes for receiving one or more electrocardiogram features from the subject, the one or more electrocardiogram features including T-wave amplitude, R-wave amplitude, T-slope, ratio of T-wave amplitude to R-wave amplitude (T/R ratio), and T-wave flatness; and
wherein the processor applies an electrocardiogram algorithm for producing the output on the serum potassium concentration in the subject based on the value of the one or more electrocardiogram features, wherein the electrocardiogram algorithm is programmed into a computer readable medium and includes one or more of the following operational rules: i) the output on the serum potassium concentration being a function of the R-wave amplitude; ii) the output on the serum potassium concentration being a function of the T-wave amplitude; iii) the output on the serum potassium concentration being a function of the T/R ratio; and iv) the output on the serum potassium concentration being a function of the T-wave flatness.

2. The medical system of claim 1 , further comprising one or more detectors including at least one of a nerve electrogram amplifier, an accelerometer, a strain gauge, and a pressure gauge for detecting the change in muscle or nerve activity.

3. The medical system of claim 1 , wherein the medical device receiving at least one electrical signal is external to the subject or implantable in the subject.

4. The medical system of claim 1 , wherein the electromyogram sensor is a skeletal muscle strain sensor.

5. The medical system of claim 1 , wherein the electromyogram sensor is a blood pressure sensor.

6. The medical system of claim 1 , wherein the output on the serum potassium concentration is a difference between a serum potassium concentration at time t 1 of the subject and a baseline potassium concentration at time t 0 of the subject, time t 1 being at least 10 minutes apart from t 0 .

7. The medical system of claim 6 , wherein the baseline serum potassium concentration is a value selected from the group consisting of a baseline serum potassium concentration of the subject obtained at a periodic blood draw, a baseline serum potassium concentration of the subject obtained at the onset of a dialysis session, and a baseline serum potassium concentration of the subject at the end of a dialysis session.

8. The medical system of claim 7 , wherein the R-wave amplitude of operational rule i) is a difference between an R-wave amplitude at time t 1 of the subject and a baseline R-wave amplitude at time t 0 of the subject, the T-wave amplitude of operational rule ii) is a difference between a T-wave amplitude at time t 1 of the subject and a baseline T-wave amplitude at time t 0 of the subject, the T/R ratio of operational rule iii) is a difference between a T/R ratio at time t 1 of the subject and a baseline T/R ratio at time t 0 of the subject, and the T-wave flatness of operational rule iv) is a difference between an T-wave flatness at time t 1 of the subject and a baseline T-wave flatness at time t 0 of the subject.

9. The medical system of claim 8 , wherein the baseline potassium concentration of the subject is 3.0 to 5.5 mM at time t 0 .

10. The medical system of claim 1 , wherein the one or more electrocardiogram electrodes include one or more of lead II, lead V2, lead V3 and lead V4.

11. The medical system of claim 1 , wherein the one or more electrocardiogram electrodes consist of lead II only.

12. The medical system of claim 1 , wherein the electrocardiogram algorithm includes one or more of the operational rules i), iii) and iv).

13. The medical system of claim 1 , wherein the output on the serum potassium concentration is in positive correlation with the R-wave amplitude.

14. The medical system of claim 1 , wherein the output on the serum potassium concentration is in negative correlation with the T-wave amplitude.

15. The medical system of claim 1 , wherein the output on the serum potassium concentration is in negative correlation with the T-slope.

16. The medical system of claim 1 , wherein the output on the serum potassium concentration is in positive correlation with the T-wave flatness.

17. The medical system of claim 1 , wherein the one or more electrocardiogram electrodes includes a first set of electrodes consisting of lead II, lead V2, lead V3 and lead V4, and a second set of electrodes consisting of lead II only, wherein the electrocardiogram algorithm further includes a calibration rule that the medical system is operationally calibrated if one or more of the following is met: v) a difference between the outputs according to rule ii) from the first set of electrodes and the second set of electrodes is no greater than 20%; vi) a difference between the outputs according to rule iii) from the first set of electrodes and the second set of electrodes is no greater than 20%; and vii) a difference between the outputs according to rule iv) from the first set of electrodes and the second set of electrodes is no greater than 20%.

18. The medical system of claim 1 , wherein the one or more electrocardiogram electrodes includes a first set of electrodes consisting of lead II, lead V2, lead V3 and lead V4, and a second set of electrodes consisting of lead II only, wherein the electrocardiogram algorithm further includes a calibration rule that the medical system is operationally calibrated if one or more of the following is met: v) a difference between the outputs according to rule ii) from the first set of electrodes and the second set of electrodes is no greater than 10%; vi) a difference between the outputs according to rule iii) from the first set of electrodes and the second set of electrodes is no greater than 10%; and vii) a difference between the outputs according to rule iv) from the first set of electrodes and the second set of electrodes is no greater than 10%.

19. The medical system of claim 1 , further comprising a dialysis device such that the subject is under serum potassium concentration monitoring while being subject to a dialysis treatment by the dialysis device.

20. The medical system of claim 1 , wherein the forward computational procedure generates a non-weighted or weighted sum of feature scores P1, P6, P7, P8 and P10 to calculate the risk score with the feature scores each assigned a zero or non-zero value based on the following:
P1 being a feature score based on P-R interval,
P6 being a feature score based on S-T segment depression,
P7 being a feature score based on T-wave inversion,
P8 being a feature score based on U-wave amplitude, and
P10 being a feature score based on heart rate variation.

21. The medical system of claim 1 , wherein the forward compu

Assignees

• Medtronic Inc

Inventors

• Soykan Orhan
• Manda Venkatesh R
• Gerber Martin T
• Hobot Christopher M
• Ruetz Linda L
• Schu Carl

Classifications

• A61B2560/0223

  of calibration, e.g. protocols for calibrating sensors · CPC title

• A61M1/14

  Dialysis systems; Artificial kidneys; Blood oxygenators (semi-permeable membranes characterised by the material, manufacturing processes therefor B01D71/00){; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis} · CPC title

• A61B5/4836

  Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence) · CPC title

• B01D61/32

  Controlling or regulating · CPC title

• A61B5/6866

  Extracorporeal blood circuits, e.g. dialysis circuits · CPC title